About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Melanoma Clinical Trials | 3,341 Studies Recruiting

Clinical TrialsMelanoma

Melanoma Clinical Trials

Browse 3,341 clinical trials for melanoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 441-460 of 3,341 trials

CompletedVaccine Therapy in Treating Patients With Stage IV or Recurrent MelanomaRATIONALE: Vaccines made from a person's cancer cells may make the body build an immune response to kill tumor cells.NCT00012064·Newport Beach, California RecruitingA Study of GC101 TIL in Advanced Melanoma98 participants will be randomly assigned 1:1 to the experimental group and the control group for the Phase II clinical trial，this trail is expected to be finished in 24 monthsNCT06703398·Beijing Active not recruitingExercise to Boost Response to Checkpoint Blockade Immunotherapy30 minutes of moderate exercise on an arm ergometer, a cycle ergometer, or a treadmill prior to each administration of standard of care checkpoint blockade immunotherapy across…NCT05358938·Tampa, Florida RecruitingInvestigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLCThe trial will test if the combination of bexmarilimab and nivolumab can help patients whose cancers have stopped responding to immunotherapy treatment.NCT07718243·Manchester and 1 other

Related Searches

skin cancertrials

Data from ClinicalTrials.govTerms

CompletedStudy of Combination Therapy With INCMGA00012 (Anti-PD-1), INCAGN02385 (Anti-LAG-3), and INCAGN02390 (Anti-TIM-3) in Participants With Select Advanced MalignanciesThe study will determine Recommended Phase 2 Dose for all study drugs, based on the safety and tolerability of the following combinations: INCAGN02385 + INCAGN02390 and…NCT04370704·Los Angeles, California and 16 others

UnknownA Study of HX008 for the Treatment of Patients With Malignant MelanomaHX008 is a humanized monoclonal antibody targeting PD-1 on T cell surface, restores T cell activity, thus enhancing immune response and has potential to treat various types of…NCT04749485·Beijing, Beijing Municipality and 10 others

RecruitingIntradermal Ipilimumab and Nivolumab in High Risk Stage II MelanomaThis open label, single country trial will test if local injection of low-dose ipilimumab and nivolumab, is safe and reduces the sentinel node positivity in high-risk stage II…NCT06240143·Amsterdam and 5 others

CompletedSorafenib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By SurgerySorafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.NCT00119249·The Bronx, New York

UnknownEfficacy and Safety Study of Niraparib in Melanoma With Genetic Homologous Recombination (HR) MutationThis open-label phase II trial studies how well niraparib works in treating patients with advanced, metastatic melanoma with the homologous recombination (HR) pathway gene…NCT03925350·San Francisco, California

WithdrawnA Study of ONCOS-102 in Combination With Other Novel Immune-therapies in Advanced Treatment-resistant Melanoma PatientsA Phase 2 study investigating the efficacy and safety of ONCOS-102 alone or in combination with balstilimab (a programmed death receptor-1 \[PD-1\] inhibitor).NCT05561491

WithdrawnVemurafenib Combined With Whole Brain Radiation Therapy or Radiosurgery in Patients With BRAF Mutation-Positive Melanoma and Brain MetastasesThis phase I trial studies the best dose of vemurafenib when combined with whole brain radiation therapy (WBRT) or stereotactic radiosurgery (SRS) in patients with v-raf murine…NCT02145910

CompletedIpilimumab + Temozolomide in Metastatic MelanomaThe goal of this clinical research study is to learn if combining ipilimumab and temozolomide can help to control metastatic melanoma.NCT01119508·Houston, Texas

TerminatedImmunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic MelanomaBackground: * The National Cancer Institute (NCI) Surgery Branch has developed an experimental therapy that involves taking white blood cells from patients' tumors, growing them…NCT01468818·Bethesda, Maryland

RecruitingCOmparison of the Use of a PERforator Flap Versus Total Skin GRAft in the Management of Loss of Substance After Resection of Cutaneous Melanoma - Pilot StudyMelanoma is an aggressive and potentially fatal skin cancer and was the fifth most commonly diagnosed cancer among both men and women in the United States in 2022.NCT07354152·Nantes, Nantes

WithdrawnStudy of the Anti-PD-1 Antibody Nivolumab in Combination With Dabrafenib and/or TrametinibThis study evaluates nivolumab in combination drug treatments involving 1) nivolumab and dabrafenib 2) nivolumab and trametinib and 3) nivolumab, dabrafenib and trametinib in…NCT02357732

RecruitingA Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)This study is researching an experimental drug called fianlimab (also known as REGN3767), combined with another medication called cemiplimab (also known as REGN2810), called…NCT06246916·Chandler, Arizona and 111 others

Active not recruitingAdjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.The purpose of the Columbus-AD study is to evaluate the efficacy and safety of 12 months of encorafenib in combination with binimetinib in adjuvant setting of BRAF V600E/K mutant…NCT05270044·CABA, Buenos Aires and 154 others

CompletedUsing High Resolution Function Imaging To Detect Melanoma and Dysplastic NeviA novel infrared imaging tool to aid in the clinical detection of atypical pigmented lesions and melanoma is developed.NCT01118832·Baltimore, Maryland

CompletedContinuous vs Intermittent Dabrafenib Plus Trametinib in BRAFV600 Mutant Stage 3 Unresectable or Metastatic MelanomaThis feasibility study aims to determine if intermittent dosing is deliverable, based on patient and professional willingness to take part in a randomised trial evaluating less…NCT03352947·Cambridge, England

RecruitingNon-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!)Patients who have undergone curative treatment may be at risk of relapse.NCT05196087·Toronto, Ontario

PreviousPage 23 of 168Next